30
Participants
Start Date
March 28, 2017
Primary Completion Date
May 19, 2021
Study Completion Date
June 30, 2023
Pembrolizumab
pembrolizumab 200mg IV every three weeks
Y90 radioembolization
The first Y90 radioembolization treatment will be administered one week after the first dose of pembrolizumab. If a second Y90 radioembolization treatment is required for bilobar disease, this should occur within 4 weeks of the initial procedure (between Cycles 2 and 3 of pembrolizumab).
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
University of Washington/Fred Hutchinson Cancer Research Center, Seattle
The University of North Carolina at Chapel Hill, Chapel Hill
Collaborators (1)
Merck Sharp & Dohme LLC
INDUSTRY
Hoosier Cancer Research Network
OTHER
Ashwin Somasundaram
OTHER